Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if combining uracil cream (UTC) with
capecitabine (Xeloda) can prevent Hand-Foot Syndrome. The study will also see what effects
UTC and capecitabine may have in patients with metastatic breast cancer.